Scancell Says Cancer Vaccine SCIB2 Will Be Given Using New Formulation
LONDON (Alliance News) - Scancell Holdings PLC said Monday cancer vaccine SCIB2 is to be administered using a new nanoparticle formulation in an early stage trial.Shares in Scancell were up Read More